On 5 June, South Africa is about to begin one of its most important HIV prevention drives in decades. The country will start to roll out an HIV prevention injection that has to be taken only twice a year. Will the launch become more than a symbolic event that shows what serious HIV prevention leadership looks like at a time when donor funding is shrinking and global uncertainty is growing?
What can the roll-out of a two-monthly HIV prevention injection learn from how the daily anti-HIV pill was introduced? Create demand, make the jab easy to get hold of and ensure it’s not stigmatised, write Wawira Nyagah and Mitchell Warren
PrEP is not a magic bullet. But we won’t end the HIV epidemic without it.
For the first time an Aids vaccine in our lifetime is possible, but scientists need money and support to make it work.